{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:07:07Z","timestamp":1791378427454,"version":"4.3.2"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ijrobp.2017.03.026","type":"journal-article","created":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T10:05:02Z","timestamp":1490609102000},"page":"1116-1123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":110,"title":["Late Cardiac Toxicity After Mediastinal Radiation Therapy for Hodgkin Lymphoma: Contributions of Coronary Artery and Whole Heart Dose-Volume Variables to Risk Prediction"],"prefix":"10.1016","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3206-1903","authenticated-orcid":false,"given":"Ezra","family":"Hahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaheena","family":"Bashir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameera","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Gospodarowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hodgson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2017.03.026_bib1","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1001\/jama.1993.03510160067031","article-title":"Factors affecting late mortality from heart disease after treatment of Hodgkin's disease","volume":"270","author":"Hancock","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1200\/JCO.2006.07.0805","article-title":"Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease","volume":"25","author":"Heidenreich","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib3","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/jnci\/djk029","article-title":"Myocardial infarction mortality risk after treatment for Hodgkin disease: A collaborative British cohort study","volume":"99","author":"Swerdlow","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib4","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1182\/blood-2006-07-034405","article-title":"Late cardiotoxicity after treatment for Hodgkin lymphoma","volume":"109","author":"Aleman","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib5","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1200\/JCO.1993.11.7.1208","article-title":"Cardiac disease following treatment of Hodgkin's disease in children and adolescents","volume":"11","author":"Hancock","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib6","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1001\/jama.290.21.2831","article-title":"Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy","volume":"290","author":"Hull","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib7","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/pbc.22664","article-title":"Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: Report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies","volume":"55","author":"Schellong","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib8","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1200\/JCO.2003.07.131","article-title":"Long-term cause-specific mortality of patients treated for Hodgkin's disease","volume":"21","author":"Aleman","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib9","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1200\/JCO.2002.08.021","article-title":"Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger","volume":"20","author":"Ng","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib10","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1200\/JCO.2010.29.8018","article-title":"Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: Final analysis of the German Hodgkin Study Group HD11 trial","volume":"28","author":"Eich","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib11","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1200\/JCO.2009.27.0421","article-title":"Outcomes for children and adolescents with cancer: Challenges for the twenty-first century","volume":"28","author":"Smith","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib12","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1000067","article-title":"Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma","volume":"363","author":"Engert","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib13","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.ijrobp.2012.08.041","article-title":"Involved node radiation therapy: An effective alternative in early-stage Hodgkin lymphoma","volume":"85","author":"Maraldo","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib14","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/annonc\/mdr439","article-title":"Minimising critical organ irradiation in limited stage Hodgkin lymphoma: A dosimetric study of the benefit of involved node radiotherapy","volume":"23","author":"Campbell","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/1748-717X-7-186","article-title":"Different IMRT solutions vs. 3D-conformal radiotherapy in early stage Hodgkin's lymphoma: Dosimetric comparison and clinical considerations","volume":"7","author":"Fiandra","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib16","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijrobp.2011.06.1959","article-title":"Consolidative involved-node proton therapy for stage IA-IIIB mediastinal Hodgkin lymphoma: Preliminary dosimetric outcomes from a phase II study","volume":"83","author":"Hoppe","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib17","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.1016\/j.ijrobp.2009.06.094","article-title":"Improving normal tissue complication probability models: The need to adopt a \u201cdata-pooling\u201d culture","volume":"76","author":"Deasy","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib18","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/j.ijrobp.2009.04.093","article-title":"Radiation dose-volume effects in the heart","volume":"76","author":"Gagliardi","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1200\/JCO.2015.63.4444","article-title":"Radiation dose-response relationship for risk of coronary heart disease in survivors of Hodgkin lymphoma","volume":"34","author":"van Nimwegen","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib20","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib21","doi-asserted-by":"crossref","first-page":"b4606","DOI":"10.1136\/bmj.b4606","article-title":"Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: Retrospective analysis of the Childhood Cancer Survivor Study cohort","volume":"339","author":"Mulrooney","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib22","doi-asserted-by":"crossref","first-page":"e557","DOI":"10.1016\/j.ijrobp.2012.06.026","article-title":"Individualized 3D reconstruction of normal tissue dose for patients with long-term follow-up: A step toward understanding dose risk for late toxicity","volume":"84","author":"Ng","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-6649-12-1","article-title":"Navigator channel adaptation to reconstruct three dimensional heart volumes from two dimensional radiotherapy planning data","volume":"12","author":"Ng","year":"2012","journal-title":"BMC Med Phys"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib24","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1118\/1.3284368","article-title":"Reconstruction of 3D lung models from 2D planning data sets for Hodgkin's lymphoma patients using combined deformable image registration and navigator channels","volume":"37","author":"Ng","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib25","series-title":"CT of the Heart: Principles and Applications","first-page":"219","article-title":"Anatomy of the coronary arteries and veins in CT imaging","author":"Van Geuns","year":"2005"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib26","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib27","series-title":"Applied Logistic Regression","author":"Hosmer","year":"2013"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib28","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/0895-4356(95)00510-2","article-title":"Importance of events per independent variable in proportional hazards analysis. I. Background, goals, and general strategy","volume":"48","author":"Concato","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib29","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/0895-4356(95)00048-8","article-title":"Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates","volume":"48","author":"Peduzzi","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib30","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1541-0420.2009.01375.x","article-title":"Time-dependent predictive accuracy in the presence of competing risks","volume":"66","author":"Saha","year":"2010","journal-title":"Biometrics"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib31","doi-asserted-by":"crossref","first-page":"e492","DOI":"10.1016\/S2352-3026(15)00153-2","article-title":"Cardiovascular disease after treatment for Hodgkin's lymphoma: An analysis of nine collaborative EORTC-LYSA trials","volume":"2","author":"Maraldo","year":"2015","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib32","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.radonc.2015.07.043","article-title":"Coronary stenosis risk analysis following Hodgkin lymphoma radiotherapy: A study based on patient specific artery segments dose calculation","volume":"117","author":"Moignier","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib33","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1080\/0284186X.2016.1182209","article-title":"Radiation dose distribution in coronary arteries in breast cancer radiotherapy","volume":"55","author":"Nilsson","year":"2016","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib34","doi-asserted-by":"crossref","first-page":"djv008","DOI":"10.1093\/jnci\/djv008","article-title":"Risk for valvular heart disease after treatment for hodgkin lymphoma","volume":"107","author":"Cutter","year":"2015","journal-title":"JNCI Journal of the National Cancer Institute"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib35","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.clon.2015.03.005","article-title":"Involved node, site, field and residual volume radiotherapy for lymphoma: A comparison of organ at risk dosimetry and second malignancy risks","volume":"27","author":"Murray","year":"2015","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib36","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.ijrobp.2011.09.020","article-title":"Risk of developing cardiovascular disease after involved node radiotherapy versus mantle field for Hodgkin lymphoma","volume":"83","author":"Maraldo","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib37","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/annonc\/mdt156","article-title":"Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma","volume":"24","author":"Maraldo","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib38","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijrobp.2015.02.030","article-title":"Optimized volumetric modulated arc therapy versus 3D-CRT for early stage mediastinal Hodgkin lymphoma without axillary involvement: A comparison of second cancers and heart disease risk","volume":"92","author":"Filippi","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib39","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ijrobp.2016.01.053","article-title":"A comparative evaluation of normal tissue doses for patients receiving radiation therapy for Hodgkin lymphoma on the Childhood Cancer Survivor Study and recent Children's Oncology Group trials","volume":"95","author":"Zhou","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.03.026_bib40","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.radonc.2016.11.007","article-title":"Inter-observer variation in delineating the coronary arteries as organs at risk","volume":"122","author":"Wennstig","year":"2017","journal-title":"Radiother Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301617307162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301617307162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T02:21:03Z","timestamp":1535941263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301617307162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0360301617307162"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2017.03.026","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Late Cardiac Toxicity After Mediastinal Radiation Therapy for Hodgkin Lymphoma: Contributions of Coronary Artery and Whole Heart Dose-Volume Variables to Risk Prediction","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2017.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}